Palisade Bio, Inc. PALI shares are trading higher Tuesday after the company announced the completion of its analysis evaluating ex-vivo bioactivation of PALI-2108.
The Details:
Palisade Bio said the findings demonstrated PALI-2108 exhibited efficient ex-vivo conversion into its active PDE4 inhibitor form in stool samples from both normal healthy volunteers and patients with ulcerative colitis (UC). The assessment showed PALI-2108 was converted into its active PDE4 inhibitor form at a mean rate of 90.1% with conversion steadily increasing over time.
“The results from this study underscore our confidence in PALI-2108 as a targeted treatment for moderate-to-severe UC,” said Dr. Mitch Jones, CMO at Palisade Bio.
“The successful bioactivation of prodrug PALI-2108 into its active PDE4 inhibitor form at consistently high conversion rates over a 24-hour period in stool samples highlights its promise as an innovative therapeutic approach for managing UCl," Jones added.
Palisade Bio shares are trending on social media and moving on heavy trading volume Tuesday. According to data from Benzinga Pro, more than 13.2 million shares have already been traded in the session, compared to the stock’s 100-day average of less than 192,000 shares.
Related News: What’s Going On With Rivian Automotive Stock?
How To Buy PALI Stock:
By now you're likely curious about how to participate in the market for Palisade Bio – be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
PALI Price Action: According to Benzinga Pro, Palisade Bio shares are up 60.8% at $6.69 at the time of publication Tuesday.
Image: Myriams-Fotos from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
